Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

University of Manchester Featured PhD Programmes
Imperial College London Featured PhD Programmes
University of Edinburgh Featured PhD Programmes
University of Kent Featured PhD Programmes
University of Reading Featured PhD Programmes
10 miles

University of East Anglia, School of Pharmacy PhD Projects, Programs & Scholarships

We have 11 University of East Anglia, School of Pharmacy PhD Projects, Programs & Scholarships

  • University of East Anglia
  • School of Pharmacy×
  • clear all
Order by 
Showing 1 to 10 of 11
  A hidden biochemical pathway in the chemical pathology of diabetes (HAMILTONCU19SF)
  Dr C Hamilton
Applications accepted all year round
In humans, the cysteine-containing tripeptide glutathione (GSH) is an essential thiol cofactor that maintains an intracellular reducing environment to protect against oxidative stress reactive oxygen species, which cause lipid, protein & DNA damage.
  Care Homes Independent Pharmacist Prescriber Study (CHIPPS): Process Evaluation (WRIGHTDU19SF)
  Prof D J Wright
Application Deadline: 31 May 2019
Care Homes Independent Pharmacist Prescriber Study1 is a five year research project funded by the National Institute of Health Research, a UK government body, and is designed to estimate the effectiveness and cost-effectiveness of pharmacist prescribers assuming responsibility for medicines management within care homes.
  Development of Novel Intraocular Devices (SAEEDAU19SF)
  Dr A Saeed, Dr M Wormstone
Application Deadline: 31 May 2019
Cataract is clouding of the lens of the eye, which can lead to vision impairment. The most common cause of cataract is ageing, but it can also develop at early ages in Children.
  Exploiting a new therapeutic target in malignant melanoma (MORRISCU19SF)
  Dr C Morris
Application Deadline: 31 May 2019
BACKGROUND. Despite recent advancements in treatment, cutaneous melanoma still remains a deadly disease once it has metastasised.
  Nanoencapsulation facilitated targeted drug delivery (QISU19SF)
  Dr S Qi, Dr M Alexander
Application Deadline: 31 May 2019
Nanoencapsulation of therapeutic agents in nanocarriers is an effective way for delivering ‘problematic’ drugs such as those with poorly aqueous solubility and biologics which are prone to degradation.
  Natural products in design of new cancer treatments (SEARCEYMU19SF) 
  Prof M Searcey
Application Deadline: 31 May 2019
Natural products are the backbone of clinically used anti-cancer agents and yet suffer from drawbacks associated with their toxicity.
  Synthesis of new DNA binding to compounds target genetic diseases such as cancer and diabetes (WALLERZU19SF)
  Dr Z Waller, Prof M Searcey
Application Deadline: 31 May 2019
Synthesis of new DNA binding compounds to target genetic diseases such as cancer and diabetes. It is often assumed that DNA exists only as the iconic Watson-Crick double helix but it can actually adopt many different types of structure depending on the sequence and environmental conditions.
  Targeting chemokine receptors to prevent cancer cell metastasis (MUELLERAU19SF)
  Dr A Mueller
Application Deadline: 10 May 2019
The migration of cancerous cells is controlled by a number of pro-inflammatory macromolecules such as chemokines and their receptors.
  Targeting the P2X7 purinergic receptor in melanoma (STOKESLU19SF)
  Dr L Stokes, Dr C Morris
Application Deadline: 31 May 2019
There is much research into trying to regain control of cell proliferation or cell death (apoptosis) in cancer. Different strategies exist to do this and a multitude of individual receptor targets are being identified in tumour cell lines and primary cells.
  What is the role for community pharmacy in identifying and referring people with undiagnosed hepatitis C directly to secondary care? (TWIGGMU19SF)
  Dr M Twigg
Applications accepted all year round
In order to meet the WHO directive to eliminate Hepatitis1, and in line with national priorities2, hepatitis C services in England face significant challenges to diagnose the 200,000 patients in the UK expected to have hepatitis C but not under specialist care2.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2018
All rights reserved.